BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 24473502)

  • 1. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
    Fragakis N; Koskinas KC; Katritsis DG; Pagourelias ED; Zografos T; Geleris P
    Am J Cardiol; 2012 Sep; 110(5):673-7. PubMed ID: 22621799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery.
    Simopoulos V; Tagarakis GI; Daskalopoulou SS; Daskalopoulos ME; Lenos A; Chryssagis K; Skoularingis I; Molyvdas PA; Tsilimingas NB; Aidonidis I
    Angiology; 2014 Apr; 65(4):294-7. PubMed ID: 23427280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy.
    Tsanaxidis N; Aidonidis I; Hatziefthimiou A; Daskalopoulou SS; Giamouzis G; Triposkiadis F; Skoularigis I
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):372-378. PubMed ID: 28182279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
    De Vecchis R; Ariano C; Giasi A; Cioppa C
    Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients.
    Simopoulos V; Hevas A; Hatziefthimiou A; Dipla K; Skoularigis I; Tsilimingas N; Aidonidis I
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):559-565. PubMed ID: 30255400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
    Miles RH; Passman R; Murdock DK
    Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.
    Reiffel JA; Camm AJ; Belardinelli L; Zeng D; Karwatowska-Prokopczuk E; Olmsted A; Zareba W; Rosero S; Kowey P;
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1048-56. PubMed ID: 26226999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
    J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
    Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
    Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
    Cybulski J; Kułakowski P; Budaj A; Danielewicz H; Maciejewicz J; Kawka-Urbanek T; Ceremuzyński L
    Clin Cardiol; 2003 Jul; 26(7):329-35. PubMed ID: 12862299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
    Burashnikov A; Sicouri S; Di Diego JM; Belardinelli L; Antzelevitch C
    J Am Coll Cardiol; 2010 Oct; 56(15):1216-24. PubMed ID: 20883928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
    Scirica BM; Belardinelli L; Chaitman BR; Waks JW; Volo S; Karwatowska-Prokopczuk E; Murphy SA; Cheng ML; Braunwald E; Morrow DA
    Europace; 2015 Jan; 17(1):32-7. PubMed ID: 25210025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.